Literature DB >> 10394

The influence of polyvinylpyrrolidone on the solution and bioavailability of hydrochlorothiazide.

O I Corrigan, R F Timoney, M J Whelan.   

Abstract

The dissolution properties of hydrochlorothiazide-PVP 10 000 mechanical mix and coprecipitate systems were qualitatively similar to those previously reported using hydroflumethiazide. Quantitative differences were dependent on the proportion of PVP present, its molecular weight and method of incorporation. Cumulative urinary excretion data from test capsule preparations showed that bioavailability was enhanced by the presence of PVP. However, the degree of enhancement was less than that expected from constant surface area disc rate studies. Dissolution tests on the capsule formulations, using the U.S.P. basket stirrer assembly, did not correlate with in vivo results. Using the Levy beaker method and a stirring speed of 40 rev min-1, good correlation between amount dissolved in 30 min and amount excreted in urine after 24 h was obtained. The dissolution tests revealed that PVP retards the initial dissolution from capsule dosage forms, probably by retarding deaggregation and dispersion of drug particles.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10394     DOI: 10.1111/j.2042-7158.1976.tb02840.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

Review 1.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

2.  Dissolution kinetics for coprecipitates of diflunisal with PVP K30.

Authors:  C Rodríguez-Espinosa; M C Martínez-Ohárriz; C Martín; M M Goñi; I Vélaz; M Sánchez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Apr-Jun       Impact factor: 2.441

3.  Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression.

Authors:  Qiuhua Luo; Qianying Zhang; Puxiu Wang
Journal:  Pharmaceutics       Date:  2022-08-21       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.